Topical imiquimod for periocular lentigo maligna

Ophthalmology

Volumn 117, Issue 12, 2010, Pages 2424-2429

  Demirci, Hakan ^a,b   Shields, Carol L ^a   Bianciotto, Carlos G ^a   Shields, Jerry A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ADULT; AGED; APPLICATION SITE DISCOMFORT; APPLICATION SITE ERYTHEMA; APPLICATION SITE REACTION; APPLICATION SITE SWELLING; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG WITHDRAWAL; EPICANTHUS; EYE BIOPSY; FEMALE; HUMAN; INTERVENTION STUDY; LOWER EYELID; MALE; MALIGNANT LENTIGO; PERIOCULAR LENTIGO MALIGNA; PRIORITY JOURNAL; PUNCH BIOPSY; RECURRENT DISEASE; RETROSPECTIVE STUDY; SKIN DISEASE; TREATMENT DURATION; TREATMENT RESPONSE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; AMINOQUINOLINES; EYELID NEOPLASMS; FEMALE; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 78649856091     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2010.03.049     Document Type: Article

References (35)

1. L.M. Cohen Lentigo maligna and lentigo maligna melanoma J Am Acad Dermatol 33 1995 923 936
2. J.H. Little, J. Holt, and N. David Changing epidemiology of malignant melanoma in Queensland Med J Aust 1 1980 66 69
3. N.A. Pospescu, C.M. Beard, and P.J. Treacy Cutaneous malignant melanoma in Rochester, Minnesota: trends in incidence and survivorship, 1950 through 1985 Mayo Clin Proc 65 1990 1293 1302
4. M.J. Donnellan, T. Seemayer, and A.G. Huvos Clinicopathologic study of cutaneous melanoma of the head and neck Am J Surg 124 1972 450 454
5. T.J. Flotte, and M.C. Mihm Jr Lentigo maligna and malignant melanoma in situ, lentigo maligna type Hum Pathol 30 1999 533 536
6. Z.S. Tannous, L.H. Lerner, and L.M. Duncan Progression to invasive melanoma from melanoma in situ, lentigo maligna type Hum Pathol 31 2000 705 708
7. J.P. Arlette, M.J. Trotter, T. Trotter, and C.L. Temple Management of lentigo maligna and lentigo maligna melanoma: seminars in surgical oncology J Surg Oncol 86 2004 179 186
8. M. Vaziri, F.V. Buffam, and M. Martinka Clinicopathologic features and behavior of cutaneous eyelid melanoma Ophthalmology 109 2002 901 908
9. B. Esmaeli, A. Youssef, A. Naderi Collaborative Eyelid Skin Melanoma Group Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group report Ophthal Plast Reconstr Surg 19 2003 96 101
10. H. Demirci, T.M. Johnson, and B.R. Frueh Management of periocular cutaneous melanoma with a staged excision technique and permanent sections: the square procedure Ophthalmology 115 2008 2295 2300
11. D.J. Hurwitz, L. Pincus, and T.S. Kupper Imiquimod: a topically applied link between innate and acquired immunity Arch Dermatol 139 2003 1347 1350
12. D. Navi, and A. Huntley Imiquimod 5 percent cream and the treatment of cutaneous malignancy Dermatol Online J 10 2004 4
13. J.K. Geisse, P. Rich, and A. Pandya Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study J Am Acad Dermatol 47 2002 390 398
14. S. Shumack, J. Robinson, and S. Kossard Efficacy of topical 5% imiquimod cream for the treatment of superficial and nodular basal cell carcinoma: comparison of dosing regimens Arch Dermatol 138 2002 1165 1171
15. A. Mackenzie-Wood, S. Kossard, and J. de Launey Imiquimod 5% in the treatment of Bowen's disease J Am Acad Dermatol 44 2001 123 125
16. A. Steinmann, J.O. Funk, G. Schuler, and P. von den Driesch Topical imiquimod treatment of a cutaneous melanoma metastasis J Am Acad Dermatol 43 2000 555 556
17. M.F. Naylor, N. Crowson, and R. Kuwahara Treatment of lentigo maligna with topical imiquimod Br J Dermatol 149 2003 66 70
18. S.F. Rajpar, and J.R. Marsden Imiquimod in the treatment of lentigo maligna Br J Dermatol 155 2006 653 656
19. I.H. Wolf, L. Cerroni, K. Kodama, and H. Kerl Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod Arch Dermatol 141 2005 510 514
20. C.J. Fleming, A.M. Bryden, and A. Evans A pilot study of treatment of lentigo maligna with 5% imiquimod cream Br J Dermatol 151 2004 485 488
21. C. Quirk, K. Gebauer, M. Owens, and P. Stampone Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks Australas J Dermatol 47 2006 258 265
22. M.E. Falagas, A.G. Angelousi, and G. Peppas Imiquimod for the treatment of actinic keratosis: a meta-analysis of randomized controlled trials J Am Acad Dermatol 55 2006 537 538
23. L. Edwards, A. Ferenczy, and L. Eron Self-administered topical 5% imiquimod cream for external anogenital warts HPV Study Group. Human Papilloma Virus Arch Dermatol 134 1998 25 30
24. Imiquimod for superficial and in situ skin malignancy Drug Ther Bull 47 2009 113 116
25. J.M. Junkins-Hopkins Imiquimod use in the treatment of lentigo maligna J Am Acad Dermatol 61 2009 865 867
26. M.A. Stanley Imiquimod and the imidazoquinolones; mechanism of action and therapeutic potential Clin Exp Dermatol 27 2002 571 577
27. B. Berman, T. Sullivan, T. De Araujo, and M. Nadji Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle Br J Dermatol 149 2003 59 61
28. M. Schon, A.B. Bong, and C. Drewniok Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod J Natl Cancer Inst 95 2003 1138 1149
29. I. Ahmed, and J. Berth-Jones Imiquimod: a novel treatment for lentigo maligna Br J Dermatol 143 2000 843 845
30. M.A. Cotter, J.K. McKenna, and G.M. Bowen Treatment of lentigo maligna with imiquimod before staged excision Dermatol Surg 34 2007 147 151
31. A.M. Powell, R. Russell-Jones, and R.J. Barlow Topical imiquimod immunotherapy in the management of lentigo maligna Clin Exp Dermatol 29 2004 15 21 (Pubitemid 38183642)
32. T. van Meurs, R. van Doorn, and G. Kirtschig Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream Dermatol Surg 33 2007 623 626 discussion 6267
33. R. Malhotra, C. Chen, and S.C. Huilgol Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma Ophthalmology 110 2003 2011 2018
34. G.H. Fisher, and P.G. Lang Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease [letter] Arch Dermatol 139 2003 945 947
35. C.S. Woodmansee, and M.W. McCall Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod Dermatol Surg 35 2009 1286 1289